Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
Pharmaceutical Statistics · 2024
DOI: 10.1002/pst.2412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Yulia Dyachkova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Merck Healthcare KGaA, Darmstadt, Germany. Hauptthemen laut MEDLINE: Drug Development, Clinical Trials as Topic, Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Single‐arm trials (SATs), while not preferred, remain in use throughout the drug development cycle. They may be accepted by regulators in particular contexts (e.g., in oncology or rare diseases) when the potential effects of new treatments are very large and placebo treatment is unethical. However, in the postregulatory space, SATs are common, and perhaps even more poorly suited to address the questions of interest. In this manuscript, we review regulatory and HTA positions on SATs; challenges posed by SATs to address research questions beyond regulators, evolving statistical methods to provide context for SATs, case studies where SATs could and could not address questions of interest, and communication strategies to influence decision making and optimize study design to address evidence needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Merck Healthcare KGaA, Darmstadt, Germany.
- Novartis AG, Basel, Switzerland.
- F Hoffman-La Roche, Basel, Switzerland.
- AstraZeneca UK Ltd, Cambridge, UK.
- GlaxoSmithKline, Stevenage, UK.
- Sanofi, Paris, France.
ORCID-Profile: Cornelia Dunger-Baldauf, Jenny Devenport
Zitieren
APA
Dyachkova, Y., Dunger-Baldauf, C., Barbier, N., Devenport, J., Franzén, S., Kazeem, G., Künzel, T., Mancini, P., Mordenti, G., Richert, K., Ridolfi, A., & Saure, D. (2024). Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2412
Vancouver
Dyachkova Y, Dunger-Baldauf C, Barbier N, Devenport J, Franzén S, Kazeem G, et al. Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2412
BibTeX
@article{Dyachkova2024,
author = {Dyachkova, Yulia and Dunger-Baldauf, Cornelia and Barbier, Nathalie and Devenport, Jenny and Franzén, Stefan and Kazeem, Gbenga and Künzel, Thomas and Mancini, Pierre and Mordenti, Giacomo and Richert, Knut and Ridolfi, Antonia and Saure, Daniel},
title = {Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space},
journal = {Pharmaceutical Statistics},
year = {2024},
doi = {10.1002/pst.2412}
}
EUVIMED